Ban on key drugs endangers China's transgender women

Ban on key drugs endangers China's transgender women Cartoon by Rebel Pepper
Photo: RFA

Transgender women in China are facing fresh obstacles after a government ban in December 2022 on onlines sale of cyproterone acetate, a widely used antiandrogen drug, and estradiol, a widely used estrogen drug. The ban on drugs needed for people who were born male to transition to female is driving trans Chinese women to the black market where they are vulnerable to being scammed, and has compounded a mental health crisis gripping the community.


Add your comment by filling out the form below in plain text. Comments are approved by a moderator and can be edited in accordance with RFAs Terms of Use. Comments will not appear in real time. RFA is not responsible for the content of the postings. Please, be respectful of others' point of view and stick to the facts.